MATCH Arm EAY131-S2

**Semantic type:** Intellectual Product

**Definition:** The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with trametinib in patients with tumors that have mutations in either the GNAQ or GNA11 gene excluding uveal melanoma.

**Synonyms:** - EAY131-S2 - S2